Renee D Gala - Net Worth and Insider Trading
Renee D Gala Net Worth
The estimated net worth of Renee D Gala is at least $7 Million dollars as of 2024-11-10. Renee D Gala is the EVP & CFO of Jazz Pharmaceuticals PLC and owns about 35,978 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $4 Million. Renee D Gala is the SVP, CFO of Theravance Biopharma Inc and owns about 171,049 shares of Theravance Biopharma Inc (TBPH) stock worth over $2 Million. Renee D Gala is also the Director of Corcept Therapeutics Inc and owns about 10,000 shares of Corcept Therapeutics Inc (CORT) stock worth over $596,000. Details can be seen in Renee D Gala's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Renee D Gala has not made any transactions after 2023-05-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Renee D Gala
Renee D Gala Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Renee D Gala owns 4 companies in total, including Gossamer Bio Inc (GOSS) , Jazz Pharmaceuticals PLC (JAZZ) , and Theravance Biopharma Inc (TBPH) among others .
Click here to see the complete history of Renee D Gala’s form 4 insider trades.
Insider Ownership Summary of Renee D Gala
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GOSS | Gossamer Bio Inc | 2019-02-07 | director |
JAZZ | Jazz Pharmaceuticals PLC | 2023-05-18 | EVP & CFO |
TBPH | Theravance Biopharma Inc | 2018-08-15 | VP-Finance |
2018-03-07 | director |
Renee D Gala Latest Holdings Summary
Renee D Gala currently owns a total of 3 stocks. Among these stocks, Renee D Gala owns 35,978 shares of Jazz Pharmaceuticals PLC (JAZZ) as of May 18, 2023, with a value of $4 Million and a weighting of 67.67%. Renee D Gala owns 171,049 shares of Theravance Biopharma Inc (TBPH) as of August 15, 2018, with a value of $2 Million and a weighting of 23.27%. Renee D Gala also owns 10,000 shares of Corcept Therapeutics Inc (CORT) as of March 7, 2018, with a value of $596,000 and a weighting of 9.07%.
Latest Holdings of Renee D Gala
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
JAZZ | Jazz Pharmaceuticals PLC | 2023-05-18 | 35,978 | 123.62 | 4,447,600 |
TBPH | Theravance Biopharma Inc | 2018-08-15 | 171,049 | 8.94 | 1,529,178 |
CORT | Corcept Therapeutics Inc | 2018-03-07 | 10,000 | 59.60 | 596,000 |
Holding Weightings of Renee D Gala
Renee D Gala Form 4 Trading Tracker
According to the SEC Form 4 filings, Renee D Gala has made a total of 2 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 6,000 shares on May 18, 2023, which brought Renee D Gala around $790,500.
According to the SEC Form 4 filings, Renee D Gala has made a total of 0 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years. The most-recent trade in Theravance Biopharma Inc is the sale of 43,743 shares on August 15, 2018, which brought Renee D Gala around $1 Million.
According to the SEC Form 4 filings, Renee D Gala has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the acquisition of 10,000 shares on March 7, 2018, which cost Renee D Gala around $155,100.
Insider Trading History of Renee D Gala
- 1
Renee D Gala Trading Performance
GuruFocus tracks the stock performance after each of Renee D Gala's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Renee D Gala is 27.75%. GuruFocus also compares Renee D Gala's trading performance to market benchmark return within the same time period. The performance of stocks bought by Renee D Gala within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Renee D Gala's insider trading performs compared to the benchmark.
Performance of Renee D Gala
Renee D Gala Ownership Network
Ownership Network List of Renee D Gala
Ownership Network Relation of Renee D Gala
Renee D Gala Owned Company Details
What does Gossamer Bio Inc do?
Who are the key executives at Gossamer Bio Inc?
Renee D Gala is the director of Gossamer Bio Inc. Other key executives at Gossamer Bio Inc include Chief Medical Officer Richard Aranda , director & Executive Chairman Faheem Hasnain , and Chief Financial Officer Bryan Giraudo .
Gossamer Bio Inc (GOSS) Insider Trades Summary
Over the past 18 months, Renee D Gala made no insider transaction in Gossamer Bio Inc (GOSS). Other recent insider transactions involving Gossamer Bio Inc (GOSS) include a net purchase of 293,570 shares made by Bryan Giraudo , a net sale of 7,740 shares made by Richard Aranda , and a net purchase of 348,828 shares made by Faheem Hasnain .
In summary, during the past 3 months, insiders sold 0 shares of Gossamer Bio Inc (GOSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 47,790 shares of Gossamer Bio Inc (GOSS) were sold and 729,000 shares were bought by its insiders, resulting in a net purchase of 681,210 shares.
Gossamer Bio Inc (GOSS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Gossamer Bio Inc Insider Transactions
Renee D Gala Mailing Address
Above is the net worth, insider trading, and ownership report for Renee D Gala. You might contact Renee D Gala via mailing address: 901 Gateway Blvd, South San Francisco Ca 94080.